Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors - PubMed (original) (raw)
Binding of beta-carbolines and related agents at serotonin (5-HT(2) and 5-HT(1A)), dopamine (D(2)) and benzodiazepine receptors
R A Glennon et al. Drug Alcohol Depend. 2000.
Abstract
A large series of beta-carbolines was examined for their ability to bind at [3H]agonist-labeled 5-HT(2A) serotonin receptors. Selected beta-carbolines were also examined at 5-HT(2C) serotonin receptors, 5-HT(1A) serotonin receptors, dopamine D(2) receptors, and benzodiazepine receptors. Indolealkylamines and phenylisopropylamines were also evaluated in some of these binding assays. The beta-carbolines were found to bind with modest affinity at 5-HT(2A) receptors, and affinity was highly dependent upon the presence of ring substituents and ring saturation. The beta-carbolines displayed little to no affinity for 5-HT(1A) serotonin receptors, dopamine D(2) receptors and, with the exception of beta-CCM, for benzodiazepine receptors. Examples of beta-carbolines, indolealkylamines (i.e. N,N-dimethyltryptamine analogs), and phenylisopropylamines have been previously shown to produce common stimulus effects in animals trained to discriminate the phenylisopropylamine hallucinogen DOM (i.e. 1-(2, 5-dimethoxy-4-methylphenyl)-2-aminopropane) from vehicle. Although the only common receptor population that might account for this action is 5-HT(2A), on the basis of a lack of enhanced affinity for agonist-labeled 5-HT(2A) receptors, as well as on their lack of agonist action in the PI hydrolysis assay, it is difficult to conclude that the beta-carbolines behave in a manner consistent with that of other classical hallucinogens.
Similar articles
- Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.
Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, Cumbay MG, Watts VJ, Barker EL, Nichols DE. Blair JB, et al. J Med Chem. 2000 Nov 30;43(24):4701-10. doi: 10.1021/jm000339w. J Med Chem. 2000. PMID: 11101361 - Investigation of hallucinogenic and related beta-carbolines.
Grella B, Dukat M, Young R, Teitler M, Herrick-Davis K, Gauthier CB, Glennon RA. Grella B, et al. Drug Alcohol Depend. 1998 Apr 1;50(2):99-107. doi: 10.1016/s0376-8716(97)00163-4. Drug Alcohol Depend. 1998. PMID: 9649961 - Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.
Asproni B, Pau A, Bitti M, Melosu M, Cerri R, Dazzi L, Seu E, Maciocco E, Sanna E, Busonero F, Talani G, Pusceddu L, Altomare C, Trapani G, Biggio G. Asproni B, et al. J Med Chem. 2002 Oct 10;45(21):4655-68. doi: 10.1021/jm020848t. J Med Chem. 2002. PMID: 12361392 - Further evidence that the discriminative stimulus properties of indorenate are mediated by 5-HT 1A/1B/2C receptors.
Miranda F, Hong E, Sánchez H, Velázquez-Martínez DN. Miranda F, et al. Pharmacol Biochem Behav. 2003 Jan;74(2):371-80. doi: 10.1016/s0091-3057(02)01010-9. Pharmacol Biochem Behav. 2003. PMID: 12479957 - Treatment strategies for senile dementia: antagonist beta-carbolines.
Sarter M, Schneider HH, Stephens DN. Sarter M, et al. Trends Neurosci. 1988 Jan;11(1):13-7. doi: 10.1016/0166-2236(88)90042-2. Trends Neurosci. 1988. PMID: 2469147 Review. No abstract available.
Cited by
- Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
Egger K, Aicher HD, Cumming P, Scheidegger M. Egger K, et al. Cell Mol Life Sci. 2024 Sep 10;81(1):395. doi: 10.1007/s00018-024-05353-6. Cell Mol Life Sci. 2024. PMID: 39254764 Free PMC article. Review. - Harmane inhibits serotonergic dorsal raphe neurons in the rat.
Touiki K, Rat P, Molimard R, Chait A, de Beaurepaire R. Touiki K, et al. Psychopharmacology (Berl). 2005 Nov;182(4):562-9. doi: 10.1007/s00213-005-0118-0. Epub 2005 Oct 19. Psychopharmacology (Berl). 2005. PMID: 16133137 - Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.
Wagner DJ, Duan H, Chapron A, Lee RW, Wang J. Wagner DJ, et al. Xenobiotica. 2017 Dec;47(12):1112-1120. doi: 10.1080/00498254.2016.1271160. Epub 2017 Mar 2. Xenobiotica. 2017. PMID: 27977936 Free PMC article. - Sequence specific binding of beta carboline alkaloid harmalol with deoxyribonucleotides: binding heterogeneity, conformational, thermodynamic and cytotoxic aspects.
Sarkar S, Pandya P, Bhadra K. Sarkar S, et al. PLoS One. 2014 Sep 23;9(9):e108022. doi: 10.1371/journal.pone.0108022. eCollection 2014. PLoS One. 2014. PMID: 25247695 Free PMC article. - The Role of Hippocampal 5HT3 Receptors in Harmaline-Induced Memory Deficit.
Nasehi M. Nasehi M. Basic Clin Neurosci. 2015 Jul;6(3):163-70. Basic Clin Neurosci. 2015. PMID: 26904173 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous